Healthcare >> CEO Interviews >> August 6, 2001
EDWARD J. LEGERE is President & Chief Executive Officer of Peregrine
Pharmaceuticals, Inc. He was appointed President and Chief Executive
Officer on April 6, 2001; he was also re-appointed as a Director on
December 29, 1999. Mr. Legere served as a Director from October 28, 1992
until September 8, 1998 when he resigned from his position for personal
reasons. Mr. Legere has been President of Unified Management Corp., a
business management, trade and consulting company, since September 1992.
Mr. Legere has been General Partner of Legere Enterprises, Ltd., a
biotechnology investment company located in Las Vegas, Nevada and an
affiliate of Techniclone (by stock ownership) since December 1991 and is
also the General Partner of Biotechnology Development, Ltd., a
biotechnology development and marketing company located in Las Vegas,
Nevada. Mr. Legere holds a BS degree in International Business from
Florida Atlantic University in Boca Raton, Florida, and an MBA from the
University of Chicago, Chicago, Illinois. Profile
Pharmaceuticals, Inc?
Mr. Legere: Peregrine was actually previously named Techniclone
Corporation, and Techniclone was
